Immatics IMTX
NASDAQ IMTX
$8.76 +0.20 (+2.29%)
As of: Sep 30, 2026 · 9:47 AM EDT

Immatics (IMTX) EV to EBITDA (2022)

Updated

Immatics' (IMTX) EV to EBITDA was 6.72 for Q4 2022, down 45.7% from the prior quarter.

Analysis

Immatics (IMTX) EV to EBITDA (2022) Analysis & Trends

For FY2022, EV to EBITDA at Immatics was 7.35.

  • Per Business Quant data, the three quarters before Q4 2022 came in at 12.37 (Q3 2022), 9.70 (Q2 2022) and 22.06 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Immatics 1.14 Bn -898.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 6.72
Sep 30, 2022 12.37
Jun 30, 2022 9.70
Mar 31, 2022 22.06
API Access

Immatics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=IMTX&period=max&api_key=YOUR_API_KEY